Related by context. Frequent words. (Click for all words.) 65 OncoGenex Technologies 64 Files Shelf Registration Statement 64 MultiCell Technologies 64 Jumps Higher 63 Bayhill Therapeutics 63 Adnexus Therapeutics 62 Trubion Pharmaceuticals 62 Nastech Pharmaceutical Company 62 Maxim Pharmaceuticals 62 Cyclacel Pharmaceuticals 62 Progenics Pharmaceuticals 62 Metabasis Therapeutics Inc. 61 Teleflex Incorporated 61 AVEO Pharmaceuticals 61 Archemix Corp. 61 CardioVascular BioTherapeutics Inc. 61 Ore Pharmaceuticals 61 Pervasip Corp. 61 Endo Pharmaceuticals ENDP 61 CoTherix Inc. 61 Ambit Biosciences 61 Idera Pharmaceuticals 61 lululemon athletica inc 61 Transcept Pharmaceuticals 61 Healthnostics Inc. 61 Symyx Technologies 61 Praecis 61 Connetics Corporation 61 Andrx Corporation 61 Urigen Pharmaceuticals Inc. 60 Alseres Pharmaceuticals Inc. 60 Sunesis Pharmaceuticals 60 Inovio Pharmaceuticals 60 Q2 Loss Narrows 60 China Aoxing Pharmaceutical 60 Enzon Pharmaceuticals 60 quotes/comstock/# * 60 Merrimack Pharmaceuticals 60 FoldRx 60 Pharmion Corporation 60 DRRX 60 Vaccinex 60 Omeros Corporation 60 Emisphere Technologies 60 Stockholders Approve Merger 60 Synergy Pharmaceuticals 60 Holds Annual Meeting 60 Covalon Technologies Ltd. 60 IMPAX Laboratories Inc. 60 Vitae Pharmaceuticals 60 Acceleron Pharma 60 Lexicon Pharmaceuticals 60 Ironwood Pharmaceuticals 60 ABII 60 VIA Pharmaceuticals 60 DepoMed 60 MacroPore Biosurgery 59 IDEC Pharmaceuticals 59 ImmunoGen Inc. 59 Nanophase Technologies 59 Achillion Pharmaceuticals Inc. 59 Northstar Neuroscience Inc. 59 Earnings Scorecard 59 Altus Pharmaceuticals Inc. 59 BioMarin Pharmaceutical 59 LeMaitre Vascular Inc. 59 Sunesis Pharmaceuticals Inc. 59 AVANIR Pharmaceuticals 59 CFO Exercises Options 59 Dynogen 59 Barrier Therapeutics Inc. 59 FluoroPharma 59 Idenix Pharmaceuticals 59 Joins OTCQX 59 Metabasis Therapeutics 59 MiddleBrook Pharmaceuticals 59 Portola Pharmaceuticals 59 Elixir Pharmaceuticals 59 EPIX Pharmaceuticals Inc. 59 SangStat 59 Q2 Profit Surges 59 CEO Exercises Options 59 Nasdaq VTIV 59 MorphoSys AG FSE MOR 59 Senesco Technologies 59 NovaBay Pharmaceuticals Inc. 59 PsychoGenics 59 Neose Technologies Inc. 59 CureDM 59 ARYx Therapeutics Inc. 59 Shareholders Approve Acquisition 59 AXYS Design Automation 59 Coley Pharmaceutical Group 59 Q3 Loss Narrows 59 ARCA biopharma Inc. 59 Q2 Loss Widens 59 Threshold Pharmaceuticals Inc. 59 Halozyme Therapeutics 58 Bearish Pressure Building 58 Immunicon Corporation 58 NASDAQ AEZS